Abiopharma

🔍 Baker Bridget (Director)

Company: LiveOne, Inc. (LVO)

Report Date: 2026-03-02

Detailed Transactions and Holdings:

• Acquired 21,153 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 21,153.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: The Restricted Stock Units (the "RSUs") were granted to the Reporting Person as director fees for service on the Issuer's board of directors (the "Board") for the period from October 1, 2024 to September 30, 2025. The RSUs shall vest on March 31, 2026 (the "Vesting Date"), subject to the Reporting Person's continued service on the Board through the Vesting Date. Each RSU represents a contingent right to receive one share of the Issuer's common stock or the cash value thereof. The Board, in its sole discretion, will determine in accordance with the terms and conditions of the Issuer's 2016 Equity Incentive Plan, as amended, the form of payout of the RSUs (cash and/or stock). The Reporting Person shall have the option to defer the settlement of the RSUs until the earlier of such time as the Reporting Person is no longer serving on the Board or up to five years from the vesting date.